Effects of behavioral sleep extension on Alzheimers disease relevant blood biomarkers and cognitive performance
Effects of behavioral sleep extension on Alzheimers disease relevant blood biomarkers and cognitive performance
批准号:
10288146
负责人:
Kelly Glazer Baron
金额:
$33.78万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-04-27 至 2025-06-30
关键词:
AcuteAdolescentAdultAgeAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAlzheimer&aposs disease riskAlzheimer’s disease biomarkerAmbulatory Blood Pressure MonitoringAmino AcidsAreaBehavioralBiochemical PathwayBiologicalBiological AssayBiological MarkersBloodBlood PressureBlood specimenBody mass indexBrainCardiometabolic DiseaseClinical TrialsCognitionCognitiveConsensusControl GroupsDataDementiaDevelopmentDiagnosticDietDiseaseDrowsinessElderlyEpidemiologyFutureGoalsGrantHealthHealth educationHourHypertensionImpact evaluationImpaired cognitionIndividualInflammationInterventionLaboratoriesLeadLearningLinkLiteratureMaintenanceMeasuresMediator of activation proteinMetabolicNational Health Interview SurveyNeurodegenerative DisordersOutcomeOutcome MeasureParentsPatient Self-ReportPerformancePhysical activityPhysiologicalPopulationPopulations at RiskQuality of lifeRandomizedRandomized Controlled TrialsRecommendationReportingResearchRiskRisk FactorsSleepSleep DisordersTestingTimeVascular DementiaVisuospatialacylcarnitinebasebehavioral phenotypingbiomarker identificationbiomarker panelbiomarker performancecardiometabolic riskcardiometabolismcognitive changecognitive performancecognitive testingcomparison interventiondementia riskdesigndisorder riskepidemiology studyexperimental studyfollow-upglycemic controlimprovedimprovement on sleepmetabolomicsmiddle agemild cognitive impairmentmodifiable risknovelpre-clinicalpredictive markerprehypertensionprimary outcomeprocessing speedpsychologicpublic health relevanceresponseresponse biomarkersecondary outcomesmall moleculetoolvigilanceyoung adult
中文摘要
项目总结/文摘
英文摘要
PROJECT SUMMARY/ABSTRACT
Decades of experimental and epidemiologic research link short sleep duration to adverse cardiometabolic
health. Furthermore, emerging research points to direct biological mechanisms linking short sleep duration to
cognitive decline and Alzheimer’s disease. Despite decades documenting the deleterious effects of short sleep
duration, few studies have sought to improve risk or modify Alzheimer’s disease trajectories by extending
sleep. Sleep extension interventions hold promise to improve cardiometabolic disease (CMD) risk, cognition
and quality of life. To date, several small studies have demonstrated short term improvements in sleep and
CMD risk such as blood pressure and glycemic control. However, existing studies in adults have not addressed
whether sleep extension interventions impact cognitive performance and biomarkers of Alzheimer’s Disease
risk. The goal of this application is to extend the aims of our parent study to include an examination of
the impact of our randomized behavioral sleep extension intervention on Alzheimer’s related
biomarkers (blood metabolomics) and cognitive performance measures. In our parent study, we are
conducting a randomized controlled trial to test our behavioral sleep extension intervention compared to a
health education control group on sleep and CMD risk among adults with prehypertension/stage I
hypertension. The 12-month study includes an intervention period (weeks 1-8, weekly intervention),
maintenance period (months 2-6, monthly intervention) and follow-up period (no intervention). The primary
outcome for the parent study is sleep duration and the main secondary outcome is 24-h ambulatory blood
pressure monitoring, which allows us to evaluate both daytime and nighttime blood pressures. The design of
this parent study will allow us to examine the acute (8 week) and sustained (12 month) changes in sleep
duration, BP and important psychological, behavioral and physiological mediators including self-reported
sleepiness, BMI, diet, physical activity, glycemic control and inflammation. The receipt of this Alzheimer’s
disease supplement will allow us to extend the scope of our parent study to examine the effects of our
sleep extension intervention on blood biomarkers and cognitive performance. Successful completion of
this study will provide critical information about the impact of behavioral sleep extension on important
measures of health and quality of life needed to incorporate sleep extension into CMD, and potentially
Alzheimer’s disease risk interventions. Completion of this supplement will identify potential biochemical
pathways and behavioral phenotypes that respond to sleep extension. Identification of these biological and
behavioral markers of response to sleep extension has the potential to lead to identification of biomarkers and
novel targets to reduce Alzheimer’s Disease risk.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Addressing sleep health disparities from within: A community-engaged study to understanding sleep and cardiometabolic disease risk among women of color
-
批准号:10815470
-
项目类别:
-
资助金额:$75.97万
-
财政年份:2023
-
负责人:Kelly Glazer Baron
-
依托单位:
Dyadic Sleep, Biobehavioral Rhythms and Cognitive Function in Older Adults: Implications for Alzheimer’s Disease
-
批准号:10584241
-
项目类别:
-
资助金额:$99.05万
-
财政年份:2023
-
负责人:Kelly Glazer Baron
-
依托单位:
Mixed Methods Evaluation of a Couples-Based Treatment to Improve CPAP Adherence and Sleep Health Among Patients with Obstructive Sleep Apnea and Increased Risk for Alzheimer's Disease
-
批准号:10339141
-
项目类别:
-
资助金额:$9.05万
-
财政年份:2020
-
负责人:Kelly Glazer Baron
-
依托单位:
Effects of a behavioral sleep extension intervention on cardiometabolic risk factors among patients with elevated BP/hypertension
-
批准号:10271243
-
项目类别:
-
资助金额:$57.97万
-
财政年份:2020
-
负责人:Kelly Glazer Baron
-
依托单位:
Effects of a behavioral sleep extension intervention on cardiometabolic risk factors among patients with elevated BP/hypertension
-
批准号:10627801
-
项目类别:
-
资助金额:$57.58万
-
财政年份:2020
-
负责人:Kelly Glazer Baron
-
依托单位:
Effects of a behavioral sleep extension intervention on cardiometabolic risk factors among patients with elevated BP/hypertension
-
批准号:10438889
-
项目类别:
-
资助金额:$55.92万
-
财政年份:2020
-
负责人:Kelly Glazer Baron
-
依托单位:
Circadian and sleep pathways to cardiometabolic disease risk: role of neurobehavioral processes
-
批准号:10364620
-
项目类别:
-
资助金额:$41.08万
-
财政年份:2019
-
负责人:Kelly Glazer Baron
-
依托单位:
Sleep, circadian rhythms: associations with diabetes risk and mood
-
批准号:10683676
-
项目类别:
-
资助金额:$7.97万
-
财政年份:2019
-
负责人:Kelly Glazer Baron
-
依托单位:
Circadian and sleep pathways to cardiometabolic disease risk: role of neurobehavioral processes
-
批准号:10545057
-
项目类别:
-
资助金额:$36.15万
-
财政年份:2019
-
负责人:Kelly Glazer Baron
-
依托单位:
Circadian and sleep pathways to cardiometabolic disease risk: role of neurobehavioral processes
-
批准号:10078973
-
项目类别:
-
资助金额:$45.65万
-
财政年份:2019
-
负责人:Kelly Glazer Baron
-
依托单位:
Circadian Timing, Sleep, and Adiposity
-
批准号:8526529
-
项目类别:
-
资助金额:$13.23万
-
财政年份:2011
-
负责人:Kelly Glazer Baron
-
依托单位:
Circadian Timing, Sleep, and Adiposity
-
批准号:8319339
-
项目类别:
-
资助金额:$13.23万
-
财政年份:2011
-
负责人:Kelly Glazer Baron
-
依托单位:
Circadian Timing, Sleep, and Adiposity
-
批准号:8709867
-
项目类别:
-
资助金额:$13.23万
-
财政年份:2011
-
负责人:Kelly Glazer Baron
-
依托单位:
Circadian Timing, Sleep, and Adiposity
-
批准号:8165036
-
项目类别:
-
资助金额:$13.23万
-
财政年份:2011
-
负责人:Kelly Glazer Baron
-
依托单位:
海外基金